FDA To Consider Behind-The-Counter Drugs
The U.S. Food and Drug Administration announced on Thursday that it will consider offering a third class of drugs, sold from behind pharmacy counters, in addition to traditional prescription and over-the-counter...To view the full article, register now.
Already a subscriber? Click here to view full article